Is once daily multimatrix mesalazine therapy effective regardless of the dose in patients with mild to moderate ulcerative colitis?.

Author: Seong Ran JEON ¹
Author Information

1. Digestive Disease Center, Institute for Digestive Research, Soonchunhyang University College of Medicine, Seoul, Korea. 94jsr@hanmail.net
Publication Type:Editorial
MeSH: Colitis, Ulcerative*; Humans; Mesalamine*; Ulcer*
From:Intestinal Research 2018;16(2):163-165
CountryRepublic of Korea
Language:English
Abstract: No abstract available.